Quest Historical Income Statement

DGX Stock  USD 131.06  2.19  1.70%   
Historical analysis of Quest Diagnostics income statement accounts such as Selling General Administrative of 1.5 B or Total Revenue of 6.9 B can show how well Quest Diagnostics Incorporated performed in making a profits. Evaluating Quest Diagnostics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Quest Diagnostics's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Quest Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Quest Diagnostics is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

About Quest Income Statement Analysis

Quest Diagnostics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Quest Diagnostics shareholders. The income statement also shows Quest investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Quest Diagnostics Income Statement Chart

Quest Diagnostics Incorporated Income Statement is one of the three primary financial statements used for reporting Quest's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Quest Diagnostics revenue and expense. Quest Diagnostics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Quest Diagnostics' EBITDA is fairly stable compared to the past year. Selling And Marketing Expenses is likely to rise to about 18.8 K in 2024, whereas Depreciation And Amortization is likely to drop slightly above 280.4 M in 2024.

Total Revenue

Total revenue comprises all receipts Quest Diagnostics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Quest Diagnostics Incorporated minus its cost of goods sold. It is profit before Quest Diagnostics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Quest Diagnostics. It is also known as Quest Diagnostics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Quest Diagnostics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
At this time, Quest Diagnostics' EBITDA is fairly stable compared to the past year. Selling And Marketing Expenses is likely to rise to about 18.8 K in 2024, whereas Depreciation And Amortization is likely to drop slightly above 280.4 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit4.2B3.4B3.1B2.7B
Total Revenue10.8B9.9B9.3B6.9B

Quest Diagnostics income statement Correlations

0.420.450.810.80.770.810.850.870.790.290.870.120.90.35-0.53-0.480.20.840.80.440.21-0.190.62
0.420.840.750.760.750.730.730.680.730.580.670.210.640.50.26-0.960.010.020.13-0.03-0.07-0.270.01
0.450.840.820.850.840.750.740.670.780.840.690.210.640.35-0.11-0.930.040.050.060.01-0.020.170.21
0.810.750.820.960.990.920.950.910.990.590.90.020.920.37-0.32-0.850.220.520.430.140.04-0.140.57
0.80.760.850.960.930.950.970.950.910.690.940.150.920.51-0.24-0.840.120.540.50.310.15-0.070.43
0.770.750.840.990.930.880.90.850.990.620.85-0.020.860.31-0.34-0.850.230.440.350.060.02-0.080.59
0.810.730.750.920.950.880.980.970.880.520.990.280.970.56-0.18-0.810.230.630.520.360.13-0.20.41
0.850.730.740.950.970.90.980.990.910.510.980.130.970.5-0.22-0.790.160.660.570.330.12-0.250.47
0.870.680.670.910.950.850.970.990.860.50.980.170.970.56-0.22-0.730.150.710.650.410.19-0.260.43
0.790.730.780.990.910.990.880.910.860.520.85-0.060.880.28-0.35-0.830.270.490.380.04-0.02-0.170.63
0.290.580.840.590.690.620.520.510.50.520.490.280.410.47-0.12-0.65-0.09-0.010.060.220.330.470.02
0.870.670.690.90.940.850.990.980.980.850.490.290.990.56-0.25-0.730.220.720.640.430.17-0.20.44
0.120.210.210.020.15-0.020.280.130.17-0.060.280.290.20.60.18-0.170.110.090.180.480.330.27-0.44
0.90.640.640.920.920.860.970.970.970.880.410.990.20.49-0.28-0.710.30.760.670.360.11-0.30.51
0.350.50.350.370.510.310.560.50.560.280.470.560.60.490.35-0.39-0.110.320.440.660.51-0.01-0.36
-0.530.26-0.11-0.32-0.24-0.34-0.18-0.22-0.22-0.35-0.12-0.250.18-0.280.35-0.06-0.17-0.48-0.32-0.05-0.07-0.32-0.81
-0.48-0.96-0.93-0.85-0.84-0.85-0.81-0.79-0.73-0.83-0.65-0.73-0.17-0.71-0.39-0.06-0.12-0.08-0.10.070.150.14-0.19
0.20.010.040.220.120.230.230.160.150.27-0.090.220.110.3-0.11-0.17-0.120.270.05-0.13-0.28-0.230.33
0.840.020.050.520.540.440.630.660.710.49-0.010.720.090.760.32-0.48-0.080.270.850.570.3-0.260.58
0.80.130.060.430.50.350.520.570.650.380.060.640.180.670.44-0.32-0.10.050.850.620.27-0.30.31
0.44-0.030.010.140.310.060.360.330.410.040.220.430.480.360.66-0.050.07-0.130.570.620.660.22-0.13
0.21-0.07-0.020.040.150.020.130.120.19-0.020.330.170.330.110.51-0.070.15-0.280.30.270.660.39-0.09
-0.19-0.270.17-0.14-0.07-0.08-0.2-0.25-0.26-0.170.47-0.20.27-0.3-0.01-0.320.14-0.23-0.26-0.30.220.39-0.1
0.620.010.210.570.430.590.410.470.430.630.020.44-0.440.51-0.36-0.81-0.190.330.580.31-0.13-0.09-0.1
Click cells to compare fundamentals

Quest Diagnostics Account Relationship Matchups

Quest Diagnostics income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization349M437M777M382M439M280.4M
Interest Expense167M175M163M138M152M99.3M
Selling General Administrative1.5B1.6B1.7B1.8B1.8B1.5B
Total Revenue7.7B9.4B10.8B9.9B9.3B6.9B
Gross Profit2.7B3.6B4.2B3.4B3.1B2.7B
Other Operating Expenses6.5B7.5B8.4B8.5B8.0B5.8B
Operating Income1.2B2.0B2.4B1.4B1.3B1.1B
Ebit1.2B2.0B2.4B1.4B1.3B1.1B
Ebitda1.6B2.4B3.2B1.8B1.3B1.3B
Cost Of Revenue5.0B5.8B6.6B6.5B6.2B4.2B
Total Operating Expenses1.5B1.7B1.8B2.0B1.6B1.6B
Income Before Tax1.1B1.9B2.6B1.2B1.1B962.5M
Total Other Income Expense Net(155M)(87M)218M(193M)(132M)(125.4M)
Net Income858M1.4B2.0B946M854M619.9M
Income Tax Expense247M460M597M264M(248M)(235.6M)
Net Income Applicable To Common Shares858M1.4B2.0B942M1.1B758.9M
Minority Interest48M68M(85M)(69M)(56M)(53.2M)
Net Income From Continuing Ops886M1.5B2.1B1.0B819M983.8M
Non Operating Income Net Other77M151M447M(11M)(12.7M)(12.0M)
Tax Provision247M460M597M264M204M266.4M
Interest Income5M163M151M138M9M8.6M
Net Interest Income(167M)(175M)(163M)(138M)(144M)(151.2M)
Reconciled Depreciation329M361M408M437M446M402.3M

Pair Trading with Quest Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Quest Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quest Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving against Quest Stock

  0.64EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.5MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.46RNLX Renalytix AI Report 4th of April 2024 PairCorr
  0.41LNSR LENSAR IncPairCorr
The ability to find closely correlated positions to Quest Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Quest Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Quest Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Quest Diagnostics Incorporated to buy it.
The correlation of Quest Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Quest Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Quest Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Quest Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Quest Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Quest Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Quest Diagnostics Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Quest Diagnostics Incorporated Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Complementary Tools for Quest Stock analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.868
Dividend Share
2.84
Earnings Share
7.48
Revenue Per Share
82.607
Quarterly Revenue Growth
(0.02)
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.